MannKind makes $12.5M pharma buy
MannKind Corp., a biotech company based in Westlake Village, announced Dec. 7 that it has acquired a QrumPharma, a privately held biotech company, in a $12.5 million deal. MannKind has purchased all outstanding capital stock of QrumPharma for $3.5 million in cash and just over 3 million shares of MannKind common stock. At MannKind’s stock Read More →
Retailers brace for a pandemic holiday
Small businesses are using the holidays to find new ways to support themselves and their communities.
Goleta’s Frinj takes coffee off state’s crop fringe and up to new levels
Coffee, South Coast’s newest emerging agribusiness; Goleta bean grower boosts state’s once-fringe crop, while shaking up traditional practices by shortening supply chain and bringing greater return to farmers.
Stimulus talks renew hope for financial relief
Conversations in Washington of a second round of economic relief are in the works, in hopes to offset the financial impact of COVID-19
New state order could close restaurants, other businesses if ICUs fill up
California Gov. Gavin Newsom announced a revised stay-at-home order on Dec. 3 that is tied to each region of the state’s intensive care capacity. In areas where the ICU capacity falls below 15%, a stay-at-home order will be implemented for three weeks. Under this new order, the state is broken into five regions, with Ventura, Read More →
Semtech reaches record highs after earnings beat
Semtech, a Camarillo semiconductor company specializing in Internet of Things applications, announced earnings on Dec. 2 that beat both the previous quarter and analysts’ estimates. Shares of Semtech were trading at just under $70 my midday on Dec. 3, the highest stock price in the company’s history. The company’s shares are up 23% in the Read More →
Amgen joins new cooperative trials for COVID treatment
With COVID-19 continuing to surge across the globe, a coalition of pharmaceutical companies including Thousand Oaks-based Amgen has announced a joint trial for new coronavirus treatments. Amgen, along with Takeda and UCB, are now collaborating to study methods of treatment for patients who are hospitalized due to COVID-19, the three companies announced. The trial enrolled Read More →
